{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T07:16:53Z","timestamp":1783322213536,"version":"3.54.6"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thrombosis J"],"DOI":"10.1186\/s12959-026-00892-3","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:46:14Z","timestamp":1783100774000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The PH score: a practical tool for screening myeloproliferative neoplasms in acute portal vein thrombosis"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0199-3791","authenticated-orcid":false,"given":"Hikmet","family":"\u00d6ztop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nevriye G\u00fcl","family":"Ada Tak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih","family":"Eren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faz\u0131l \u00c7a\u011fr\u0131","family":"Hunutlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6khan","family":"Ocako\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"892_CR1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jceh.2014.12.008","volume":"5","author":"YK Chawla","year":"2015","unstructured":"Chawla YK, Bodh V. Portal vein thrombosis. J Clin Exp Hepatol. 2015;5:22\u201340. https:\/\/doi.org\/10.1016\/j.jceh.2014.12.008.","journal-title":"J Clin Exp Hepatol"},{"key":"892_CR2","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.3748\/wjg.v12.i13.2115","volume":"12","author":"M Ogren","year":"2006","unstructured":"Ogren M, Bergqvist D, Bj\u00f6rck M, Acosta S, Eriksson H, Sternby NH. Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies. World J Gastroenterol. 2006;12:2115\u20139. https:\/\/doi.org\/10.3748\/wjg.v12.i13.2115.","journal-title":"World J Gastroenterol"},{"key":"892_CR3","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1002\/ajh.26896","volume":"98","author":"J-J Kiladjian","year":"2023","unstructured":"Kiladjian J-J, Cassinat B. Myeloproliferative neoplasms and splanchnic vein thrombosis: Contemporary diagnostic and therapeutic strategies. Am J Hematol. 2023;98:794\u2013800. https:\/\/doi.org\/10.1002\/ajh.26896.","journal-title":"Am J Hematol"},{"key":"892_CR4","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms. Leukemia. 2022;36:1703\u201319. https:\/\/doi.org\/10.1038\/s41375-022-01613-1.","journal-title":"Leukemia"},{"key":"892_CR5","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1056\/NEJMoa051113","volume":"352","author":"R Kralovics","year":"2005","unstructured":"Kralovics R, Passamonti F, Buser AS, Teo S-S, Tiedt R, Passweg JR, et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med. 2005;352:1779\u201390. https:\/\/doi.org\/10.1056\/NEJMoa051113.","journal-title":"N Engl J Med"},{"key":"892_CR6","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/nature03546","volume":"434","author":"C James","year":"2005","unstructured":"James C, Ugo V, Le Cou\u00e9dic J-P, Staerk J, Delhommeau F, Lacout C, et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature. 2005;434:1144\u20138. https:\/\/doi.org\/10.1038\/nature03546.","journal-title":"Nature"},{"key":"892_CR7","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1056\/NEJMra063728","volume":"355","author":"PJ Campbell","year":"2006","unstructured":"Campbell PJ, Green AR. The myeloproliferative disorders. N Engl J Med. 2006;355:2452\u201366. https:\/\/doi.org\/10.1056\/NEJMra063728.","journal-title":"N Engl J Med"},{"key":"892_CR8","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","volume":"365","author":"EJ Baxter","year":"2005","unstructured":"Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet (London England). 2005;365:1054\u201361. https:\/\/doi.org\/10.1016\/S0140-6736(05)71142-9.","journal-title":"Lancet (London England)"},{"key":"892_CR9","doi-asserted-by":"publisher","first-page":"329","DOI":"10.7326\/0003-4819-103-3-329","volume":"103","author":"D Valla","year":"1985","unstructured":"Valla D, Casadevall N, Lacombe C, Varet B, Goldwasser E, Franco D, et al. Primary myeloproliferative disorder and hepatic vein thrombosis. A prospective study of erythroid colony formation in vitro in 20 patients with Budd-Chiari syndrome. Ann Intern Med. 1985;103:329\u201334. https:\/\/doi.org\/10.7326\/0003-4819-103-3-329.","journal-title":"Ann Intern Med"},{"key":"892_CR10","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/0016-5085(88)90567-7","volume":"94","author":"D Valla","year":"1988","unstructured":"Valla D, Casadevall N, Huisse MG, Tulliez M, Grange JD, Muller O, et al. Etiology of portal vein thrombosis in adults. A prospective evaluation of primary myeloproliferative disorders. Gastroenterology. 1988;94:1063\u20139. https:\/\/doi.org\/10.1016\/0016-5085(88)90567-7.","journal-title":"Gastroenterology"},{"key":"892_CR11","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391\u2013405. https:\/\/doi.org\/10.1182\/blood-2016-03-643544.","journal-title":"Blood"},{"key":"892_CR12","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s12072-017-9810-5","volume":"12","author":"D-C Valla","year":"2018","unstructured":"Valla D-C. Budd-Chiari syndrome\/hepatic venous outflow tract obstruction. Hepatol Int. 2018;12:168\u201380. https:\/\/doi.org\/10.1007\/s12072-017-9810-5.","journal-title":"Hepatol Int"},{"key":"892_CR13","doi-asserted-by":"publisher","first-page":"4921","DOI":"10.1182\/blood-2011-09-376517","volume":"120","author":"JH Smalberg","year":"2012","unstructured":"Smalberg JH, Arends LR, Valla DC, Kiladjian J-J, Janssen HLA, Leebeek FWG. Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis. Blood. 2012;120:4921\u20138. https:\/\/doi.org\/10.1182\/blood-2011-09-376517.","journal-title":"Blood"},{"key":"892_CR14","doi-asserted-by":"publisher","first-page":"4922","DOI":"10.1182\/blood-2007-11-125328","volume":"111","author":"J-J Kiladjian","year":"2008","unstructured":"Kiladjian J-J, Cervantes F, Leebeek FWG, Marzac C, Cassinat B, Chevret S, et al. The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases. Blood. 2008;111:4922\u20139. https:\/\/doi.org\/10.1182\/blood-2007-11-125328.","journal-title":"Blood"},{"key":"892_CR15","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jhep.2017.04.021","volume":"67","author":"J Poisson","year":"2017","unstructured":"Poisson J, Plessier A, Kiladjian J-J, Turon F, Cassinat B, Andreoli A, et al. Selective testing for calreticulin gene mutations in patients with splanchnic vein thrombosis: A prospective cohort study. J Hepatol. 2017;67:501\u20137. https:\/\/doi.org\/10.1016\/j.jhep.2017.04.021.","journal-title":"J Hepatol"},{"key":"892_CR16","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.thromres.2018.05.007","volume":"167","author":"M Li","year":"2018","unstructured":"Li M, De Stefano V, Song T, Zhou X, Guo Z, Zhu J, et al. Prevalence of CALR mutations in splanchnic vein thrombosis: A systematic review and meta-analysis. Thromb Res. 2018;167:96\u2013103. https:\/\/doi.org\/10.1016\/j.thromres.2018.05.007.","journal-title":"Thromb Res"},{"key":"892_CR17","doi-asserted-by":"publisher","first-page":"e230128","DOI":"10.1148\/rg.230128","volume":"43","author":"AM Bozzato","year":"2023","unstructured":"Bozzato AM, Bruno O, Payance A, Plessier A, Chouard A, Rautou P-E, et al. Portal Vein Thrombosis: Baveno VII Consensus Recommendations for Diagnosis and Management. Radiogr Rev Publ Radiol Soc North Am Inc. 2023;43:e230128. https:\/\/doi.org\/10.1148\/rg.230128.","journal-title":"Radiogr Rev Publ Radiol Soc North Am Inc"},{"key":"892_CR18","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/j.1538-7836.2007.02424.x","volume":"5","author":"V De Stefano","year":"2007","unstructured":"De Stefano V, Fiorini A, Rossi E, Za T, Farina G, Chiusolo P, et al. Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders. J Thromb Haemost. 2007;5:708\u201314. https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02424.x.","journal-title":"J Thromb Haemost"},{"key":"892_CR19","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1002\/hep.21435","volume":"44","author":"M Primignani","year":"2006","unstructured":"Primignani M, Barosi G, Bergamaschi G, Gianelli U, Fabris F, Reati R, et al. Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis. Hepatology. 2006;44:1528\u201334. https:\/\/doi.org\/10.1002\/hep.21435.","journal-title":"Hepatology"},{"key":"892_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1538-7836.2006.02277.x","volume":"5","author":"D Colaizzo","year":"2007","unstructured":"Colaizzo D, Amitrano L, Tiscia GL, Scenna G, Grandone E, Guardascione MA, et al. The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis. J Thromb Haemost. 2007;5:55\u201361. https:\/\/doi.org\/10.1111\/j.1538-7836.2006.02277.x.","journal-title":"J Thromb Haemost"},{"key":"892_CR21","doi-asserted-by":"publisher","first-page":"42","DOI":"10.5152\/tjg.2015.5738","volume":"26","author":"S Karak\u00f6se","year":"2015","unstructured":"Karak\u00f6se S, Oru\u00e7 N, Zengin M, Akarca US, Ers\u00f6z G. Diagnostic value of the JAK2 V617F mutation for latent chronic myeloproliferative disorders in patients with Budd-Chiari syndrome and\/or portal vein thrombosis. Turkish J Gastroenterol Off J Turkish Soc Gastroenterol. 2015;26:42\u20138. https:\/\/doi.org\/10.5152\/tjg.2015.5738.","journal-title":"Turkish J Gastroenterol Off J Turkish Soc Gastroenterol"},{"key":"892_CR22","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/ajh.25677","volume":"95","author":"E Sant\u2019Antonio","year":"2020","unstructured":"Sant\u2019Antonio E, Guglielmelli P, Pieri L, Primignani M, Randi ML, Santarossa C, et al. Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases. Am J Hematol. 2020;95:156\u201366. https:\/\/doi.org\/10.1002\/ajh.25677.","journal-title":"Am J Hematol"},{"key":"892_CR23","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1002\/hep.21489","volume":"44","author":"HLA Janssen","year":"2006","unstructured":"Janssen HLA, Leebeek FWG. JAK2 mutation: The best diagnostic tool for myeloproliferative disease in splanchnic vein. thrombosis? Hepatol. 2006;44:1391\u20133. https:\/\/doi.org\/10.1002\/hep.21489.","journal-title":"thrombosis? Hepatol"},{"key":"892_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jhep.2020.06.045","volume":"74","author":"M Magaz","year":"2021","unstructured":"Magaz M, Alvarez-Larr\u00e1n A, Colomer D, L\u00f3pez-Guerra M, Garc\u00eda-Criado M\u00c1, Mezzano G, et al. Next-generation sequencing in the diagnosis of non-cirrhotic splanchnic vein thrombosis. J Hepatol. 2021;74:89\u201395. https:\/\/doi.org\/10.1016\/j.jhep.2020.06.045.","journal-title":"J Hepatol"},{"key":"892_CR25","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00277-014-2249-z","volume":"94","author":"A Iurlo","year":"2015","unstructured":"Iurlo A, Cattaneo D, Gianelli U, Fermo E, Augello C, Cortelezzi A. Molecular analyses in the diagnosis of myeloproliferative neoplasm-related splanchnic vein thrombosis. Ann Hematol. 2015;94:881\u20132. https:\/\/doi.org\/10.1007\/s00277-014-2249-z.","journal-title":"Ann Hematol"},{"key":"892_CR26","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s11239-012-0738-2","volume":"34","author":"I Yonal","year":"2012","unstructured":"Yonal I, Pinarbas\u0131 B, Hindilerden F, Hancer VS, Nalcaci M, Kaymakoglu S, et al. The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis. J Thromb Thrombolysis. 2012;34:388\u201396. https:\/\/doi.org\/10.1007\/s11239-012-0738-2.","journal-title":"J Thromb Thrombolysis"},{"key":"892_CR27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12959-018-0187-z","volume":"16","author":"G Greenfield","year":"2018","unstructured":"Greenfield G, McMullin MF. Splanchnic venous thrombosis in JAK2 V617F mutation positive myeloproliferative neoplasms - long term follow-up of a regional case series. Thromb J. 2018;16:33. https:\/\/doi.org\/10.1186\/s12959-018-0187-z.","journal-title":"Thromb J"},{"key":"892_CR28","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00277-007-0386-3","volume":"87","author":"A Alvarez-Larr\u00e1n","year":"2008","unstructured":"Alvarez-Larr\u00e1n A, Arellano-Rodrigo E, Reverter JC, Domingo A, Villamor N, Colomer D, et al. Increased platelet, leukocyte, and coagulation activation in primary myelofibrosis. Ann Hematol. 2008;87:269\u201376. https:\/\/doi.org\/10.1007\/s00277-007-0386-3.","journal-title":"Ann Hematol"},{"key":"892_CR29","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1182\/blood-2009-08-238956","volume":"115","author":"T Barbui","year":"2010","unstructured":"Barbui T, Carobbio A, Cervantes F, Vannucchi AM, Guglielmelli P, Antonioli E, et al. Thrombosis in primary myelofibrosis: incidence and risk factors. Blood. 2010;115:778\u201382. https:\/\/doi.org\/10.1182\/blood-2009-08-238956.","journal-title":"Blood"},{"key":"892_CR30","doi-asserted-by":"publisher","unstructured":"De Moner B, Martinez-Sanchez J, Garrote M, Ramos A, Ventosa-Capell H, Moreno-Casta\u00f1o A, et al. Endothelial damage in JAK2V617F myeloproliferative neoplasms with splanchnic vein thrombosis. Thromb Haemost. 2025. https:\/\/doi.org\/10.1055\/a-2498-4849.","DOI":"10.1055\/a-2498-4849"},{"key":"892_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41408-025-01317-6","volume":"15","author":"T Barbui","year":"2025","unstructured":"Barbui T, Ghirardi A, Empson V, Fenili F, Loscocco GG, Condorelli A, et al. Neutrophil-to-Lymphocyte ratio as surrogate for JAK2V617F suppression and event-free survival in polycythemia vera. Blood Cancer J. 2025;15:1\u201310. https:\/\/doi.org\/10.1038\/s41408-025-01317-6.","journal-title":"Blood Cancer J"}],"container-title":["Thrombosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12959-026-00892-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-026-00892-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-026-00892-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T07:03:31Z","timestamp":1783321411000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12959-026-00892-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["892"],"URL":"https:\/\/doi.org\/10.1186\/s12959-026-00892-3","relation":{},"ISSN":["1477-9560"],"issn-type":[{"value":"1477-9560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"24 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted per the ethical principles outlined in the Declaration of Helsinki (1975) and received approval from the Clinical Research Ethics Committee of the Bursa Uludag University Faculty of Medicine (Decision no: 2024-20\/6, Approval Date: 18 December 2024). Informed consent for this retrospective study was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"64"}}